Novel inhibition of cis/trans retinoic acid interconversion in biological fluids -: an accurate method for determination of trans and 13-cis retinoic acid in biological fluids

被引:13
|
作者
Wang, CJ
Pao, LH
Hsiong, CH
Wu, CY
Whang-Peng, JJK
Hu, OYP
机构
[1] Natl Def Med Ctr, NeiHu, Taipei 11490, Taiwan
[2] Natl Hlth Res Inst, Canc Res Ctr, Taipei, Taiwan
[3] Natl Def Med Ctr, Pharmaceut Res Inst, Taipei 11490, Taiwan
[4] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 796卷 / 02期
关键词
interconversion; pharmacokinetics; retinoic acid;
D O I
10.1016/S1570-0232(03)00572-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
All-trans retinoic acid (tRA, or tretinoin) can be metabolized through stereoisomerzation to 13-cis retinoic acid (13-cRA) in vivo. We have developed a simple, sensitive and accurate method for analyzing tRA and 13-cRA in plasma with the addition of N-ethylmaleimide (NEM) and Vitamin C (Vit. C) to prevent the interconversion of cis/trans retinoic acid. All-trans RA, 9-cRA, and 13-cRA were well separated from each other in plasma by using a C18 precolumn and a column with a gradient solvent system of mobile phases A and B at a flow rate of 1.0 ml/min. In addition, thermal stability of tRA and cRA in plasma during the sample preparation under the temperature of 0 and 25 degreesC were studied. Our results showed that (1) the interconversion ratios (%) (cRA/tRA and tRA/cRA) were decreased with the addition of NEM and Vit. C and the minimum concentrations of NEM and Vit. C to inhibit the interconversion were 50 and 150 muM, respectively, (2) higher concentrations of NEM and Vit. C were required to prevent the interconversion at higher temperature, (3) the precision and accuracy of calibration curve with various concentration of tRA (1-1000 ng/ml) and 13-cRA (5-800 ng/ml) in plasma showed good linearity (r(2) = 0.9992 and 0.9994), and between-day errors expressed by coefficient of variation (CV, %) for tRA and 13-cRA which were both less than 5.6%, (4) the mean recovery of the analytes were 78-94% for tRA and 80-92% for 13-cRA at concentration range from 1 to 1000 ng/ml and 5 to 800 ng/ml, respectively, and (5) the limit of quantitation of tRA and 13-cRA were 1 and 5 ng/ml, respectively. In addition, the HPLC method had been successfully applied to the tRA pharmacokinetic study in two hepatoma patients after receiving 45 mg/m(2) per day orally. Thus, our results suggest that the HPLC method for analyzing tRA and 13-cRA in plasma with the addition of NEM and Vit. C is a simple, sensitive and accurate method. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条
  • [11] 13-CIS RETINOIC ACID IN MYELODISPLASTIC SYNDROMES
    CIOLLI, S
    LEONI, F
    FERRINI, PR
    BLUT, 1988, 56 (06): : C14 - C14
  • [12] DETERMINATION OF THE KINETICS OF DEGRADATION OF 13-CIS-RETINOIC ACID AND ALL-TRANS-RETINOIC ACID IN SOLUTION
    TAN, XY
    MELTZER, N
    LINDENBAUM, S
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (09) : 817 - 822
  • [13] The analysis of all-trans, 9-cis and 13-cis retinoic acid in rat serum.
    Enriquez, JI
    Bhattacharyya, SN
    Smiley, RA
    CLINICAL CHEMISTRY, 2001, 47 (06) : A193 - A193
  • [14] IDENTIFICATION OF 13-CIS RETINOIC ACID IN TISSUE EXTRACTS AND ITS BIOLOGICAL ACTIVITY IN RATS
    ZILE, MH
    EMERICK, RJ
    DELUCA, HF
    BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 141 (03) : 639 - &
  • [15] Serum concentrations of all-trans and 13-cis retinoic acid and retinol are closely correlated
    Fex, GA
    Larsson, K
    NilssonEhle, I
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1996, 7 (03): : 162 - 165
  • [16] METABOLISM OF ALL-TRANS-RETINOIC AND 13-CIS-RETINOIC ACID IN THE CHICK
    HALLEY, BA
    AHERN, KG
    BACHLE, KJ
    HINTZ, CF
    THAYER, RH
    NELSON, EC
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 341 - 341
  • [17] DISPOSITION AND METABOLISM OF 13-CIS AND ALL-TRANS-RETINOIC ACID IN THE PLASMA OF CYNOMOLGUS MONKEYS - A COMPARISON TO A HUMAN CASE-STUDY WITH 13-CIS-RETINOIC ACID
    SLIKKER, W
    CREECHKRAFT, J
    BAILEY, JR
    ROBERTS, LG
    FISCHER, B
    WITTFOHT, W
    NAU, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) : 1873 - 1874
  • [18] Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings
    Geiger, JM
    Hommel, L
    Harms, M
    Saurat, JH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (03) : 513 - 515
  • [19] Defining the metabolic pathways of 13-cis retinoic acid
    Sonawane, Poonam
    Singh, Hardeep
    Reynolds, C. Patrick
    Kang, Min H.
    CANCER RESEARCH, 2013, 73 (08)
  • [20] ROSACEA - ORAL TREATMENT WITH 13-CIS RETINOIC ACID
    NIKOLOWSKI, J
    PLEWIG, G
    HAUTARZT, 1980, 31 (12): : 660 - 661